Ontology highlight
ABSTRACT: Purpose of review
The prevalence of cancer therapy-related cardiac dysfunction (CTRCD) is increasing due to improved cancer survival. Serial monitoring of cardiac function is essential to detect CTRCD, guiding timely intervention strategies. Multigated radionuclide angiography (MUGA) has been the main screening tool using left ventricular ejection fraction (LVEF) to monitor cardiac dysfunction. However, transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging (CMR) may be more suitable for serial assessment. We aimed to assess the concordance between different non-radiating imaging modalities with MUGA to determine whether they can be used interchangeably.Recent findings
In order to identify relevant studies, a PubMed search was performed. We included cro
SUBMITTER: Printezi MI
PROVIDER: S-EPMC9177497 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature